Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NexLife vs RxSaludable

NexLife
Graded #149

Higher grade

vs+5.5
RxSaludable
Graded #264

Lower grade

The verdict

NexLife takes it — 68.5/100 to 63/100.

NexLife grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNexLife +20
70
50
Dose & formulationRxSaludable +13
64
77
Clinical oversightNexLife +7
89
82
Labs & monitoringEven
53
53
FulfillmentRxSaludable +9
67
76
Contract termsNexLife +35
55
20
NexLife · left barRxSaludable · right bar

The numbers

MetricNexLifeRxSaludable
WeighScore68.5/10063/100
GradeCC
Scorecard rank#149#264
Semaglutide$165/mo (compounded)$179/mo (compounded)
Tirzepatide$215/mo (compounded)$269/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
NexLife

Graded #149 · C

Strengths

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset

Where it loses points

  • State availability not publicly disclosed
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity
  • Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
RxSaludable

Graded #264 · C

Strengths

  • Spanish-language platform with Spanish-speaking, U.S.-licensed providers — a genuine gap in GLP-1 telehealth
  • Compounded semaglutide $99 first month ($179/mo after) and tirzepatide $189 first month; same price at every dose, no membership fee
  • LegitScript-certified (#50274281); free expedited shipping; named obesity-medicine physicians
  • Same-day doctor visits, 24/7 support, FSA/HSA eligible, cancel anytime

Where it loses points

  • Ongoing prices ($179-289/mo) are mid-range once the first-month intro ends
  • Doesn't name its compounding pharmacy partners (generic 'certified pharmacies')
  • No legal entity name or explicit state-coverage list published on the site
  • Compounded GLP-1s are not FDA-approved (the site discloses this)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard